Clinical Trial Update: Assessing the Effects of Omega-3 Supplementation on Some Serum BDNF، Follistatin، Irisin Levels in Men With CAD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating omega-3 supplementation effects on serum BDNF, follistatin, and irisin in men with coronary artery disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease

Drugs mentioned

• Omega-3 Fatty Acid Supplement (omega-3 fatty acids)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Cardiovascular Disease | Phase 4 | Status: COMPLETED